It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Background . Zygomycosis is an increasingly emerging life-threatening infection. There is
no single comprehensive literature review that describes the epidemiology and outcome of …

Aspergillus species have emerged as an important cause of life-threatening infections in
immunocompromised patients. This expanding population is composed of patients with …

Background Invasive fungal diseases (IFDs) remain important causes of morbidity and
mortality. The consensus definitions of the Infectious Diseases Group of the European …

Background. The incidence and epidemiology of invasive fungal infections (IFIs), a leading
cause of death among hematopoeitic stem cell transplant (HSCT) recipients, are derived …

Background. Invasive fungal infections (IFIs) are a major cause of morbidity and mortality
among organ transplant recipients. Multicenter prospective surveillance data to determine …

Mucormycosis is an emerging angioinvasive infection caused by the ubiquitous filamentous
fungi of the Mucorales order of the class of Zygomycetes. Mucormycosis has emerged as the …

Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …

Background. Zygomycosis is an emerging opportunistic mycosis among immunocompromised
patients with a particularly poor prognosis. Methods. We analyzed the impact of delaying …

Background Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The
SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients …